Sansure Biotech Inc (688289) - Total Liabilities

Latest as of September 2025: CN¥2.24 Billion CNY ≈ $328.38 Million USD

Based on the latest financial reports, Sansure Biotech Inc (688289) has total liabilities worth CN¥2.24 Billion CNY (≈ $328.38 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 688289 cash flow metrics to assess how effectively this company generates cash.

Sansure Biotech Inc - Total Liabilities Trend (2017–2024)

This chart illustrates how Sansure Biotech Inc's total liabilities have evolved over time, based on quarterly financial data. Check 688289 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Sansure Biotech Inc Competitors by Total Liabilities

The table below lists competitors of Sansure Biotech Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Qingdao Haier Biomedical Co Ltd SHG:688139	China	CN¥1.17 Billion
Ruentex Industries Ltd TW:2915	Taiwan	NT$14.00 Billion
Edifier Technology Co Ltd SHE:002351	China	CN¥577.26 Million
Longkou Union Chemical Co. Ltd. A SHE:301209	China	CN¥205.12 Million
La-Z-Boy Incorporated NYSE:LZB	USA	$907.30 Million
New Guomai Digital Culture Co Ltd SHG:600640	China	CN¥935.95 Million
Trident Limited NSE:TRIDENT	India	Rs26.00 Billion
Shenzhen Xinyichang Technology Co. Ltd. A SHG:688383	China	CN¥1.58 Billion

Liability Composition Analysis (2017–2024)

This chart breaks down Sansure Biotech Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 688289 company net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	4.88	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.31	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.24	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Sansure Biotech Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Sansure Biotech Inc (2017–2024)

The table below shows the annual total liabilities of Sansure Biotech Inc from 2017 to 2024.

Year	Total Liabilities	Change
2024-12-31	CN¥1.26 Billion ≈ $184.09 Million	+22.22%
2023-12-31	CN¥1.03 Billion ≈ $150.62 Million	-38.03%
2022-12-31	CN¥1.66 Billion ≈ $243.05 Million	+134.26%
2021-12-31	CN¥709.03 Million ≈ $103.75 Million	+0.01%
2020-12-31	CN¥708.95 Million ≈ $103.74 Million	+734.17%
2019-12-31	CN¥84.99 Million ≈ $12.44 Million	-45.43%
2018-12-31	CN¥155.76 Million ≈ $22.79 Million	-16.54%
2017-12-31	CN¥186.62 Million ≈ $27.31 Million	--

About Sansure Biotech Inc

SHG:688289 China Medical Instruments & Supplies

Market Cap

$1.46 Billion

CN¥9.97 Billion CNY

Market Cap Rank

#7534 Global

#1835 in China

Share Price

CN¥17.21

Change (1 day)

+0.35%

52-Week Range

CN¥17.13 - CN¥22.94

All Time High

CN¥81.40